President ´s Corner (Mitteilungen der Deutschen Schmerzgesellschaft e.V.)
Schmerz. 2024 Apr;38(2):167-168. doi: 10.1007/s00482-024-00809-x.NO ABSTRACTPMID:38517539 | DOI:10.1007/s00482-024-00809-x (Source: Schmerz)
Source: Schmerz - March 22, 2024 Category: Anesthesiology Source Type: research

Mitteilungen der SPS
Schmerz. 2024 Apr;38(2):169-170. doi: 10.1007/s00482-024-00803-3.NO ABSTRACTPMID:38517540 | DOI:10.1007/s00482-024-00803-3 (Source: Schmerz)
Source: Schmerz - March 22, 2024 Category: Anesthesiology Source Type: research

Mitteilungen der Österreichischen Schmerzgesellschaft
Schmerz. 2024 Apr;38(2):171. doi: 10.1007/s00482-024-00805-1.NO ABSTRACTPMID:38517541 | DOI:10.1007/s00482-024-00805-1 (Source: Schmerz)
Source: Schmerz - March 22, 2024 Category: Anesthesiology Source Type: research

Interdisciplinary multimodal pain therapy between "gold standard" and "terra incognita"
Schmerz. 2024 Apr;38(2):77-79. doi: 10.1007/s00482-023-00749-y. Epub 2024 Mar 22.NO ABSTRACTPMID:38517538 | DOI:10.1007/s00482-023-00749-y (Source: Schmerz)
Source: Schmerz - March 22, 2024 Category: Anesthesiology Authors: Rainer Sabatowski Johannes Lutz Source Type: research

President ´s Corner (Mitteilungen der Deutschen Schmerzgesellschaft e.V.)
Schmerz. 2024 Apr;38(2):167-168. doi: 10.1007/s00482-024-00809-x.NO ABSTRACTPMID:38517539 | DOI:10.1007/s00482-024-00809-x (Source: Schmerz)
Source: Schmerz - March 22, 2024 Category: Anesthesiology Source Type: research

Mitteilungen der SPS
Schmerz. 2024 Apr;38(2):169-170. doi: 10.1007/s00482-024-00803-3.NO ABSTRACTPMID:38517540 | DOI:10.1007/s00482-024-00803-3 (Source: Schmerz)
Source: Schmerz - March 22, 2024 Category: Anesthesiology Source Type: research

Mitteilungen der Österreichischen Schmerzgesellschaft
Schmerz. 2024 Apr;38(2):171. doi: 10.1007/s00482-024-00805-1.NO ABSTRACTPMID:38517541 | DOI:10.1007/s00482-024-00805-1 (Source: Schmerz)
Source: Schmerz - March 22, 2024 Category: Anesthesiology Source Type: research

Patient-reported outcomes in chronic diseases under treatment with cannabis medicines : Analysis of the results of the Copeia survey
CONCLUSION: A symptom matrix (SMX) composed of different symptoms seems to play a special role in CAM therapy to improve the quality of life of chronically ill patients, regardless of the underlying disease. The SMX could contribute to the identification of an indication and to targeted treatment monitoring.PMID:38451340 | DOI:10.1007/s00482-024-00802-4 (Source: Schmerz)
Source: Schmerz - March 7, 2024 Category: Anesthesiology Authors: Knud Gastmeier Andr é Ihlenfeld Anne Gastmeier Garvin Hirt Assaf Landschaft Stefan Wirz Source Type: research

Patient-reported outcomes in chronic diseases under treatment with cannabis medicines : Analysis of the results of the Copeia survey
CONCLUSION: A symptom matrix (SMX) composed of different symptoms seems to play a special role in CAM therapy to improve the quality of life of chronically ill patients, regardless of the underlying disease. The SMX could contribute to the identification of an indication and to targeted treatment monitoring.PMID:38451340 | DOI:10.1007/s00482-024-00802-4 (Source: Schmerz)
Source: Schmerz - March 7, 2024 Category: Anesthesiology Authors: Knud Gastmeier Andr é Ihlenfeld Anne Gastmeier Garvin Hirt Assaf Landschaft Stefan Wirz Source Type: research

Patient-reported outcomes in chronic diseases under treatment with cannabis medicines : Analysis of the results of the Copeia survey
CONCLUSION: A symptom matrix (SMX) composed of different symptoms seems to play a special role in CAM therapy to improve the quality of life of chronically ill patients, regardless of the underlying disease. The SMX could contribute to the identification of an indication and to targeted treatment monitoring.PMID:38451340 | DOI:10.1007/s00482-024-00802-4 (Source: Schmerz)
Source: Schmerz - March 7, 2024 Category: Anesthesiology Authors: Knud Gastmeier Andr é Ihlenfeld Anne Gastmeier Garvin Hirt Assaf Landschaft Stefan Wirz Source Type: research

Patient-reported outcomes in chronic diseases under treatment with cannabis medicines : Analysis of the results of the Copeia survey
CONCLUSION: A symptom matrix (SMX) composed of different symptoms seems to play a special role in CAM therapy to improve the quality of life of chronically ill patients, regardless of the underlying disease. The SMX could contribute to the identification of an indication and to targeted treatment monitoring.PMID:38451340 | DOI:10.1007/s00482-024-00802-4 (Source: Schmerz)
Source: Schmerz - March 7, 2024 Category: Anesthesiology Authors: Knud Gastmeier Andr é Ihlenfeld Anne Gastmeier Garvin Hirt Assaf Landschaft Stefan Wirz Source Type: research

Patient-reported outcomes in chronic diseases under treatment with cannabis medicines : Analysis of the results of the Copeia survey
CONCLUSION: A symptom matrix (SMX) composed of different symptoms seems to play a special role in CAM therapy to improve the quality of life of chronically ill patients, regardless of the underlying disease. The SMX could contribute to the identification of an indication and to targeted treatment monitoring.PMID:38451340 | DOI:10.1007/s00482-024-00802-4 (Source: Schmerz)
Source: Schmerz - March 7, 2024 Category: Anesthesiology Authors: Knud Gastmeier Andr é Ihlenfeld Anne Gastmeier Garvin Hirt Assaf Landschaft Stefan Wirz Source Type: research

Patient-reported outcomes in chronic diseases under treatment with cannabis medicines : Analysis of the results of the Copeia survey
CONCLUSION: A symptom matrix (SMX) composed of different symptoms seems to play a special role in CAM therapy to improve the quality of life of chronically ill patients, regardless of the underlying disease. The SMX could contribute to the identification of an indication and to targeted treatment monitoring.PMID:38451340 | DOI:10.1007/s00482-024-00802-4 (Source: Schmerz)
Source: Schmerz - March 7, 2024 Category: Anesthesiology Authors: Knud Gastmeier Andr é Ihlenfeld Anne Gastmeier Garvin Hirt Assaf Landschaft Stefan Wirz Source Type: research

Patient-reported outcomes in chronic diseases under treatment with cannabis medicines : Analysis of the results of the Copeia survey
CONCLUSION: A symptom matrix (SMX) composed of different symptoms seems to play a special role in CAM therapy to improve the quality of life of chronically ill patients, regardless of the underlying disease. The SMX could contribute to the identification of an indication and to targeted treatment monitoring.PMID:38451340 | DOI:10.1007/s00482-024-00802-4 (Source: Schmerz)
Source: Schmerz - March 7, 2024 Category: Anesthesiology Authors: Knud Gastmeier Andr é Ihlenfeld Anne Gastmeier Garvin Hirt Assaf Landschaft Stefan Wirz Source Type: research

Patient-reported outcomes in chronic diseases under treatment with cannabis medicines : Analysis of the results of the Copeia survey
CONCLUSION: A symptom matrix (SMX) composed of different symptoms seems to play a special role in CAM therapy to improve the quality of life of chronically ill patients, regardless of the underlying disease. The SMX could contribute to the identification of an indication and to targeted treatment monitoring.PMID:38451340 | DOI:10.1007/s00482-024-00802-4 (Source: Schmerz)
Source: Schmerz - March 7, 2024 Category: Anesthesiology Authors: Knud Gastmeier Andr é Ihlenfeld Anne Gastmeier Garvin Hirt Assaf Landschaft Stefan Wirz Source Type: research